VC  KensaGroup

     Office Locations:

950 Danby Road, Suite 300
Ithaca, NY 14850
Phone: 607-330-2307
Fax: 607-330-2319



  • Early



  • Consumer Products & Services
  • Energy & Clean Tech
  • Financial Services
  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare
  • Manufacturing & Industrial
  • Medical Device



    KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization. KensaGroup focuses on technologies that address looming economic or regulatory issues. KensaGroup's business model centers on a network of university and corporate partners that leverages the capabilities of a team. KensaGroup was launched in 2000 and has evaluated over 3,000 technologies for commercialization opportunities. The scientific backbone of KensaGroup's portfolio is chemistry-centric. The breadth of the portfolio is such that it touches a diverse array of industries including biotech, chemicals, materials, energy, medical device, pharmaceutical, financial services, agriculture, electronics and automotive industries.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Bruce Ganem Ph.D. Director
    Eric D. Eisenhut Managing Director
    Eugene Yarussi Director
    Kirsten Johnston Barker Entrepreneur in Residence
    Peter Hessney Director of Consulting and Advisory Services


    Portfolio companies include:

        web link

      Fina Technologies
        web link

      Gene Network Sciences
        web link

      GNS Healthcare
        web link

        web link

        web link

        web link

        web link

      North Sea Resins
        web link

        web link

        web link

        web link


    Recent News: